Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conversion Disorder | 4 | 2021 | 201 | 1.220 |
Why?
|
| Brain | 21 | 2022 | 27175 | 0.710 |
Why?
|
| Nerve Net | 7 | 2021 | 2306 | 0.660 |
Why?
|
| Endophenotypes | 1 | 2020 | 258 | 0.590 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2020 | 2417 | 0.560 |
Why?
|
| Myotonic Dystrophy | 3 | 2021 | 78 | 0.510 |
Why?
|
| Nervous System Diseases | 3 | 2021 | 1657 | 0.480 |
Why?
|
| Motor Cortex | 2 | 2020 | 1004 | 0.470 |
Why?
|
| Amygdala | 2 | 2020 | 1376 | 0.460 |
Why?
|
| Cerebral Cortex | 6 | 2022 | 5756 | 0.400 |
Why?
|
| tau Proteins | 5 | 2022 | 2111 | 0.370 |
Why?
|
| Brain Mapping | 8 | 2021 | 6595 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2022 | 36547 | 0.260 |
Why?
|
| Visual Cortex | 3 | 2020 | 1081 | 0.260 |
Why?
|
| Cognition | 2 | 2019 | 7050 | 0.230 |
Why?
|
| Executive Function | 3 | 2021 | 1395 | 0.210 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 234 | 0.200 |
Why?
|
| Alzheimer Disease | 6 | 2022 | 8722 | 0.200 |
Why?
|
| Neuronal Plasticity | 3 | 2021 | 1447 | 0.190 |
Why?
|
| Neural Pathways | 3 | 2019 | 3079 | 0.170 |
Why?
|
| Anticipation, Psychological | 1 | 2020 | 90 | 0.170 |
Why?
|
| Dystrophin | 1 | 2021 | 283 | 0.170 |
Why?
|
| Synaptic Vesicles | 1 | 2021 | 187 | 0.170 |
Why?
|
| Stuttering | 1 | 2019 | 24 | 0.170 |
Why?
|
| Investments | 1 | 2021 | 148 | 0.160 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 410 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 541 | 0.150 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2018 | 58 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 3 | 2022 | 3892 | 0.150 |
Why?
|
| Putamen | 1 | 2019 | 288 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2019 | 335 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 470 | 0.140 |
Why?
|
| Pain Threshold | 1 | 2021 | 609 | 0.140 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 389 | 0.140 |
Why?
|
| Aging | 3 | 2021 | 8723 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 290 | 0.140 |
Why?
|
| Movement Disorders | 1 | 2020 | 461 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 360 | 0.140 |
Why?
|
| Semantics | 1 | 2020 | 609 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 1117 | 0.140 |
Why?
|
| Calcium Channels | 1 | 2020 | 622 | 0.130 |
Why?
|
| Membrane Potentials | 1 | 2019 | 1085 | 0.130 |
Why?
|
| Positron-Emission Tomography | 3 | 2022 | 6545 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2019 | 751 | 0.120 |
Why?
|
| Lysosomes | 1 | 2019 | 932 | 0.110 |
Why?
|
| Dopamine | 1 | 2021 | 1582 | 0.110 |
Why?
|
| Adult | 18 | 2021 | 223110 | 0.110 |
Why?
|
| Social Behavior | 1 | 2020 | 1143 | 0.110 |
Why?
|
| Space Perception | 1 | 2016 | 469 | 0.110 |
Why?
|
| Cortical Spreading Depression | 1 | 2017 | 288 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2017 | 508 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 584 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22230 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 1677 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 1889 | 0.100 |
Why?
|
| Humans | 35 | 2022 | 766019 | 0.100 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 1118 | 0.100 |
Why?
|
| Visual Pathways | 1 | 2016 | 554 | 0.100 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1885 | 0.100 |
Why?
|
| Male | 21 | 2021 | 363880 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 948 | 0.100 |
Why?
|
| Visual Perception | 2 | 2020 | 1392 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2018 | 1218 | 0.100 |
Why?
|
| DNA Primers | 1 | 2016 | 2823 | 0.100 |
Why?
|
| Thalamus | 1 | 2018 | 1040 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 1742 | 0.100 |
Why?
|
| Female | 21 | 2021 | 396174 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1088 | 0.090 |
Why?
|
| Models, Biological | 2 | 2018 | 9446 | 0.090 |
Why?
|
| Rest | 1 | 2015 | 940 | 0.090 |
Why?
|
| Hippocampus | 2 | 2020 | 3774 | 0.080 |
Why?
|
| Gene Expression | 2 | 2020 | 7581 | 0.080 |
Why?
|
| Young Adult | 8 | 2021 | 59858 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9525 | 0.080 |
Why?
|
| Seizures | 1 | 2022 | 2997 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2718 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2224 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2885 | 0.070 |
Why?
|
| Decision Making | 1 | 2021 | 3954 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6057 | 0.070 |
Why?
|
| Middle Aged | 13 | 2021 | 223035 | 0.070 |
Why?
|
| Pain | 1 | 2021 | 5089 | 0.070 |
Why?
|
| Proteins | 1 | 2020 | 5994 | 0.060 |
Why?
|
| Atrophy | 2 | 2020 | 1627 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4399 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 11906 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12061 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 3213 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15882 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 35 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2022 | 457 | 0.040 |
Why?
|
| Pain Perception | 1 | 2021 | 197 | 0.040 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2020 | 83 | 0.040 |
Why?
|
| Child | 4 | 2021 | 80567 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 2020 | 80 | 0.040 |
Why?
|
| Aged | 7 | 2021 | 171170 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 247 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2019 | 253 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2022 | 665 | 0.040 |
Why?
|
| Individuality | 1 | 2019 | 303 | 0.040 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2016 | 17 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1459 | 0.030 |
Why?
|
| Anisotropy | 1 | 2019 | 1285 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2021 | 1075 | 0.030 |
Why?
|
| Heterozygote | 1 | 2022 | 2796 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2022 | 1193 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 1365 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8925 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 26280 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 30210 | 0.020 |
Why?
|
| Plasmids | 1 | 2016 | 2266 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2021 | 3576 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59497 | 0.020 |
Why?
|
| Synapses | 1 | 2020 | 1759 | 0.020 |
Why?
|
| Memory | 1 | 2020 | 2192 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1895 | 0.020 |
Why?
|
| Heart Rate | 1 | 2020 | 4203 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9540 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7118 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 88808 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3360 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8723 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 4209 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13614 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4463 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18382 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 4627 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39233 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 13464 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41677 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81544 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 168801 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_